Inspire Medical Systems (INSP) Cost of Revenue (2017 - 2026)

Inspire Medical Systems has disclosed Cost of Revenue across 10 years of filings, most recently posting $29.1 million for Q2 2026.

• In Q2 2026, Cost of Revenue fell 16.01% year-over-year to $29.1 million; the TTM figure through Jun 2026 stood at $124.6 million (down 6.83% YoY), while the FY2025 annual figure was $133.2 million, up 8.33% from the prior year.
• Cost of Revenue came in at $29.1 million for Q2 2026 at Inspire Medical Systems, up from $27.7 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $36.1 million in Q4 2025 to a low of $10.0 million in Q1 2022.
• Average Cost of Revenue over 5 years is $26.4 million, with a median of $27.9 million recorded in 2023.
• Year-over-year, Cost of Revenue surged 129.43% in 2022 and slipped 16.01% in 2026.
• Over 5 years, Cost of Revenue stood at $22.2 million in 2022, then rose by 26.64% to $28.1 million in 2023, then gained by 28.28% to $36.0 million in 2024, then gained by 0.23% to $36.1 million in 2025, then decreased by 19.26% to $29.1 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $29.1 million in Q2 2026, $27.7 million in Q1 2026, and $36.1 million in Q4 2025.